CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
European Patent
16701948.8
Filed on 2017-07-23
16701948.8
Filed on 2017-07-23
LIVE ATTENUATED FLAVIRUS VACCINES AND METHODS OF USING AND MAKING SAME
Patent Cooperation Treaty
PCT/US2018/012346
Filed on 2018-01-04
PCT/US2018/012346
Filed on 2018-01-04
CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
China
201680008108.2
Filed on 2017-07-31
201680008108.2
Filed on 2017-07-31
CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
US Application 15/547,365
Filed on 2017-07-28
Filed on 2017-07-28
CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
Mexico
MX/a/2017/009889
Filed on 2017-07-30
MX/a/2017/009889
Filed on 2017-07-30
CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
Patent Cooperation Treaty
PCT/EP16/051854
Filed on 2016-01-28
PCT/EP16/051854
Filed on 2016-01-28
CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
United Kingdom
1501523.3
Filed on 2015-01-30
1501523.3
Filed on 2015-01-30
Complete Sequence Of The Genome Of Avian Parayxovirus Type 2
US Patent 9,937,196
Filed on 2010-06-21
Filed on 2010-06-21
CD47-targeted Therapies For The Treatment Of Infectious Disease
Ireland
14748994.2
Filed on 2014-02-05
14748994.2
Filed on 2014-02-05